Table 1 Patient demographics and baseline characteristics
Neuroendoscopy group (n = 28) | Non-neuroendoscopy group (n = 39) | P-value | |
|---|---|---|---|
Age (year)1 | 15 (9, 37) | 12 (7, 25) | 0.712 |
Gender, n (%)2 | 0.018* | ||
Male | 7 (25.0) | 21 (53.8) | |
Female | 21 (75.0) | 18 (46.2) | |
Location, n (%)3 | 0.810 | ||
Left lateral ventricle body | 7 (25.0) | 12 (30.8) | |
Right lateral ventricle body | 16 (57.1) | 16 (41.0) | |
Left lateral ventricle trigone area | 2 (7.1) | 7 (17.9) | |
Right lateral ventricle trigone area | 2 (7.1) | 4 (10.3) | |
Septum pellucidum | 1 (3.6) | 0 (0.0) | |
Cyst size (cm2)1 | 6 (2, 6) | 6 (6, 12) | 0.002* |
Symptoms, n (%)3 | |||
Headache | 16 (57.1) | 25 (64.1) | 0.617 |
Vomiting | 16 (57.1) | 25 (64.1) | 0.617 |
Double vision | 2 (7.1) | 0 (0.0) | 0.171 |
Intelligence decline | 4 (14.3) | 2 (5.1) | 0.227 |
Paresis | 3 (10.7) | 0 (0.0) | 0.068 |